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Abstract
Background: Alveolar septation marks the beginning of the transition from the saccular to alveolar stage of lung
development. Inflammation can disrupt this process and permanently impair alveolar formation resulting in alveolar
hypoplasia as seen in bronchopulmonary dysplasia in preterm newborns. NF-B is a transcription factor central to
multiple inflammatory and developmental pathways including dorsal-ventral patterning in fruit flies; limb, mammary and
submandibular gland development in mice; and branching morphogenesis in chick lungs. We have previously shown
that epithelial overexpression of NF-B accelerates lung maturity using transgenic mice. The purpose of this study was to
test our hypothesis that targeted deletion of NF-B signaling in lung epithelium would impair alveolar formation.
Methods: We generated double transgenic mice with lung epithelium-specific deletion of IKKb, a known activating
kinase upstream of NF-B, using a cre-loxP transgenic recombination strategy. Lungs of resulting progeny were
analyzed at embryonic and early postnatal stages to determine specific effects on lung histology, and mRNA and
protein expression of relevant lung morphoreulatory genes. Lastly, results measuring expression of the angiogenic
factor, VEGF, were confirmed in vitro using a siRNA-knockdown strategy in cultured mouse lung epithelial cells.
Results: Our results showed that IKKb deletion in the lung epithelium transiently decreased alveolar type I and
type II cells and myofibroblasts and delayed alveolar formation. These effects were mediated through increased
alveolar type II cell apoptosis and decreased epithelial VEGF expression.
Conclusions: These results suggest that epithelial NF-B plays a critical role in early alveolar development possibly
through regulation of VEGF.
Keywords: Inhibitor of kappa-B kinase beta (IKKβ), alveolar development, alveolar maturation, Nuclear factor κB
(NF-κB), Nkx2.1, surfactant protein C (SP-C), thyroid transcription factor (TTF-1), apoptosis, vascular endothelial
growth factor (VEGF)
Background
Lung morphogenesis is broadly divided into defined
stages that extend from prenatal into early postnatal life
including embryonic, pseudoglandular, canalicular, sac-
cular, and alveolar phases. Alveolar formation is a tightly
regulated developmental process describing the transi-
tion of lung architecture from the saccular to alveolar
phenotype that begins with the formation of secondary
crests or ‘septation’ of terminal saccules. Extension of
septae is accompanied by thinning via loss of interstitial
mesenchymal cells, capillary remodeling and differentia-
tion of cuboidal epithelial cells into surfactant-producing
alveolar type II (AT2) cells. Alveolar development is
finally completed following an isotropic growth phase
during which a portion of alveolar type II cells undergo
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any medium, provided the original work is properly cited.apoptosis while others differentiate into alveolar type I
(AT1) cells as gas-exchange surface area increases to
maximal levels [reviewed in [1]]. Although the precise
details driving septation, apoptosis, and differentiation of
cuboidal cells into alveolar type II cells are not comple-
tely understood, numerous factors including transcrip-
tion factors, signaling molecules, and extracellular
matrix components are known to participate in this
complex process.
Nuclear Factor kB (NF-B) is a family of transcription
factors involved in regulation of growth, differentiation,
and apoptosis of several tissues including embryonic
limb, liver, skin, bone, and lung [2-13]. NF-Be x i s t si n
the cytoplasm in unstimulated cells as a homo- or het-
erodimer of five structurally related proteins (RelA
( p 6 5 ) ,c - R e l ,R e l - B ,N F - B1 and NF-B2) with a con-
served Rel-homology domain [14]. Extracellular stimuli
such as growth factors, cytokines, and other pathogens
activate a cascade of enzymatic reactions acting through
inhibitor of IB-kinases (IKKb–canonical pathway;
IKKa–non-canonical pathway) that lead to release of
NF-B for nuclear translocation and gene transcription.
We have previously shown that overexpression of the
RelA subunit of NF-B targeted to lung epithelium
increased alveolar type II cells through inhibition of
apoptosis [15], confirming previous reports supporting a
role of NF-B in lung morphogenesis [10,16,17].
To date, numerous studies have established the contri-
bution of tissue remodeling through apoptosis as a phy-
siologically relevant event during postnatal alveolar
development. While apoptosis in the pseudoglandular
and canalicular stages of lung development primarily
involves the lung mesenchyme, epithelial apoptosis
begins in the canalicular stage and extends through the
saccular stage until the completion of alveolar formation
[18-20]. Studies have also shown that excessive or pre-
mature alveolar epithelial apoptosis may be a central
event in the pathogenesis of disorders of alveolar hypo-
plasia such as BPD [21]. The primary epithelial cell type
that undergoes apoptosis during normal lung develop-
ment is the alveolar type II cell. The fate of AT2 cells
may be critically important since they serve as the puta-
tive stem cell for AT1 cells responsible for gas exchange,
and since they express an abundance of vascular
endothelial growth factor (VEGF) [22] critical for pul-
monary capillary development. Given the major regula-
tory function of NF-B as a controller of apoptosis, this
property suggests a potential link between NF-B signal-
ing and airspace remodeling during alveolar formation.
T h ep u r p o s eo ft h ec u r r e n ts t u d yw a st oi n v e s t i g a t e
t h er o l eo fN F - B in regulating lung alveolar develop-
ment. Based on our previous report that targeted epithe-
lial overexpression of NF-B induced lung maturation
[15], we hypothesized that the converse, namely
inactivation of canonical NF-B signaling through con-
ditional deletion of epithelial IKKb upstream of NF-B,
would impair alveolar formation. To test this hypothesis,
we crossed mice expressing the enzyme Cre recombi-
nase in lung epithelium (Nkx2.1
Cre) to mice containing
loxP sites flanking exon 3 of IKKb (IKKb
F/F) to generate
double transgenic mice (Nkx2.1
Cre; IKKb
F/F) with deleted
IKKb in lung epithelium. We found that targeted epithe-
lial deletion of IKKb delayed alveolar formation as
demonstrated by fewer alveolar type I and type II cells
during early alveolar development. The decrease in
epithelial cell numbers was associated with increased
cell apoptosis and decreased VEGF expression. Our ani-
mal model suggests that baseline expression of epithelial
NF-B plays a critical role in regulating early alveolar
development.
Methods
Generation of Nkx2.1;IKKß
F/F double transgenic mice
Inactivation of NF-B signaling in lung epithelium by
selectively targeting the gene encoding IKKb was carried
out by using a Cre/loxP recombination strategy. IKKb
F/F
mice (C57BL background strain) were a generous gift of
Michael Karin (UCSD) and are homozygous for alleles
containing loxP sites flanking Exon 3 of the mouse
IKKb gene which codes for the ATP binding site of the
IKKb kinase domain [23,24]. To delete the ‘floxed’ IKKb
alleles in lung epithelium, IKKb
F/F mice were crossed
with transgenic Nkx2.1-Cre mice (kindly provided by S.
Anderson, Cornell University, NY). Nkx2.1 promoter
activity is localized to the thyroid, forebrain, and lung
epithelium during early lung morphogenesis and is sub-
sequently localized in the lung to alveolar type II cells
following lung maturation. Our previous experience
with this mouse line identifies recombination events
throughout the developing lung epithelium using b-
galactosidase staining in a Rosa26R reporter mouse line
[25,26].
Transgenic mice were identified by PCR genotyping
analysis of tail biopsies as previously described [25,27].
PCR primers and conditions were as follows: Nkx2.1-
Cre genotyping F: [5’- ACG-AGT-GAT-GAG-GTT-
CGC-AA-3’]; R: [5’-AGC-GTT-TTC-GTT-CTG-CCA-
AT-3’]; IKKb F: [5’-TGA-CCCGGG-AAT-GAA-TAG-
CA-3’]a n dR :[ 5 ’-GTC-TTC-AAC-CTC-CCA-AGC-
CTT-3’]; conditions [2 min denaturation at 95°C fol-
lowed by 35 cycles of 95/55/72°C for 30 s/30 s/1 min
and final extension of 72°C for 5 min].
Analysis of IKKß allele deletion
Tissue specific deletion of IKKb was confirmed by PCR
of genomic DNA obtained from lung tissue using the
following primers for recombination analysis: Primer a:
[5’-TGA-CCC-GGG-AAT-GAA-TAG-CA-3’]; Primer b:
Londhe et al. Respiratory Research 2011, 12:134
http://respiratory-research.com/content/12/1/134
Page 2 of 16[5’-GTC-TTC-AAC-CTC-CCA-AGC-CTT-3’]; Primer c:
[5’ TAG-TCC-AAC-TGG-CAG-CGA-ATA-C-3’]; Pri-
mer d: [5’-CGC-CTA-GGT-AAG-ATG-GCT-GTC-T-3’]
Primer combination a-b was used to detect the intact
floxed allele and c-d was used to detect the allele with
Exon 3 deletion following PCR conditions noted above.
Deletion of IKKb in epithelial cells was further verified
by quantification of IKKb mRNA and protein in lung
tissue. Real-time quantitative PCR analysis of lung
mRNA from total lung RNA extraction using primers
specific for murine IKKb ( I k b k b )w a sp e r f o r m e da s
described below to compare IKKb levels in double
transgenic mice to littermate controls (see mRNA analy-
sis below). Deletion of IKKß protein in epithelial cells
was demonstrated via immunohistochemical analysis
using an antibody specific for murine IKKb (Abcam
Inc., Cambridge, MA) (see Immunohistochemistry
below).
Animal Husbandry
All mice were maintained in a barrier facility, and ani-
mals were handled under IACUC approved protocols.
No serological evidence of viral or bacterial pathogens
was detected in sentinel mice maintained with the col-
ony and no evidence of infection was noted at necropsy.
T h eN k x 2 . 1 - C r em i c ew e r em a i n t a i n e da n db r e da s
hemizygous and the IKKb
F/F as homozygous colonies.
Histology and Immunohistochemistry
Tissue sections were prepared from select fetal (E12-
E18), neonatal (postnatal days 0 & 7), and young adult-
hood (postnatal day 30) mouse lungs fixed in 4% Parafor-
maldehyde solution. To obtain fetal tissue, dams were
euthanized using intraperitoneal pentobarbital (100 mg/
kg) and fetuses were removed by hysterotomy. Embryo-
nic lungs were then carefully dissected en-bloc and
immersed in fixative overnight. Postnatal animals were
euthanized as above and the thoracic cavity was then
exposed and lungs were perfused free of blood with 1 ml
0.9% normal saline via the spontaneously beating right
ventricle under constant pressure of 25 cm H2O. A 26
gauge angiocatheter was used to cannulate the trachea
and inflation-fix the lungs at 25 cm H2Of o r1m i n .T i s -
sue was immersion-fixed overnight, dehydrated through
a series of alcohols and CitriSolv
® solution (Fisher Scien-
tific, Pittsburgh, PA), and embedded in paraffin. Serial 5-
μm-thick sections were cut and placed on glass slides.
Tissue sections were stained with hematoxylin and eosin
in order to analyze histopathological changes in the tis-
sue. In preparation for immunohistochemistry, slides
were cleared in CitriSolv
® and rehydrated through a
graded series of alcohols. Slides were then stained using
the Histomouse Streptavidin Peroxidase kit (Zymed
Laboratories Inc., South San Francisco, CA) as described
by the manufacturer. The optimal dilution for the rabbit
anti-ki67 antibody (Cell Signaling Technology, Inc., Dan-
vers, MA) was 1:50 dilution, rabbit anti-TTF-1 antibody
(Seven Hills Bioreagents, Cincinnati, OH) was 1:1000
dilution, rabbit anti-IKKb antibody (Abcam Inc., Cam-
bridge, MA) was 1:50 dilution, rabbit anti-Pro SP-C anti-
body (Seven Hills Bioreagents, Cincinnati, OH) was
1:1000 dilution, mouse monoclonal anti-aSMA antibody
(Sigma, Inc., St. Louis, MO) was 1:500 dilution, and goat
anti-VEGF antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) was 1:50 dilution. Normal rabbit serum
or mouse IgG was used in place of the primary antibody
in negative control slides as appropriate. The T1a anti-
body developed by Dr. Andrew Farr was used at 1:100
dilution and was obtained from the Developmental Stu-
dies Hybridoma Bank developed under the auspices of
the NICHD and maintained by The University of Iowa,
Department of Biological Sciences, Iowa City, IA 52242.
A fluorescein anti-hamster or anti-mouse IgG secondary
antibody (Vector Laboratories, Inc., Burlingame, CA) was
also used at 1:100 dilution (15 μg/ml) as suggested by the
manufacturer. All negative control slides showed no
immunostain.
Lung Morphometric Analysis
Four random 5 μm paraffin-embedded tissue sections
were taken from three different double transgenic
Nkx2.1; IKKb
F/F and control IKKb
F/F lungs at specified
stages and separately stained with hematoxylin and
eosin or immunostained with anti-TTF-1 or anti-SP-C
antibody as described above. The sections were photo-
graphed using a SPOT Insight QE camera and software
(Diagnostic Instruments, Inc., Sterling Heights, MI) and
each image file was analyzed in a blinded manner using
the NIH ImageJ 1.37 v program to quantify the number
of cells stained positively for the specified antibody. The
mean ± SEM was generated and compared between
double transgenic and control sections.
Radial alveolar counts were measured as previously
described [28]. Briefly, a line was drawn from the center
of a respiratory bronchiole to the nearest interlobular
septum, to which an intercept line was drawn perpendi-
cularly. The number of distal air sacs that were trans-
ected by the intercept line was counted. This assessment
was repeated for a minimum of ten terminal respiratory
units in one random tissue section per mouse. The
mean ± SEM was generated and compared between
double transgenic and control sections.
Quantification of alveolar type I cells was estimated
using the NIH ImageJ 1.37 v program by first converting
T1a immunofluorescence images into a binary compo-
site highlighting all pixels specific for the corresponding
color channel (Cy3). The total number of pixels was
then summated and compared from a minimum of 5
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previously described [29].
Hart’s elastin stain
As previously described [30] slides were cleared in Citri-
Solv
®, rehydrated through graded alcohols and then
incubated overnight in Hart’s Solution (9:1 solution of
Weigert’s Iron resorcin fuchsin and 1% HCl. Slides were
then rinsed in ethanol, 1% HCl, and water before being
incubated for 1 hour in Weigert’s Iron Hematoxylin,
rinsed in water, and then incubated for 5 minutes in
Van Gieson’s Picro-Fuchsin. Slides were dehydrated
through graded alcohols, mounted with a xylene based
mounting medium, and photographed using a SPOT
Insight QE camera and software (Diagnostic Instru-
ments, Inc., Sterling Heights, MI).
mRNA Analysis
mRNA was extracted from lungs of double transgenic
Nkx2.1; IKKb
F/F mice and control IKKb
F/F littermate
controls at specified embryonic and postnatal stages by
snap-freezing immediately after dissection and transfer
to -80°C until homogenization using a hand-held power
homogenizer followed by subsequent organic-solvent
extraction with TRIzol and chloroform (Invitrogen
Corp., Carlsbad, CA) as described by the manufacturer.
Total RNA (1 μg) was reverse-transcribed into cDNA
and amplified using the TaqMan Reverse Transcription
Kit PCR Kit (Applied Biosystems, Foster City, CA).
Real-time quantitative PCR using primers to detect
mouse IKKb ( I k b k b ) ,m u r i n eN k x 2 . 1 ,a l s or e f e r r e dt oa s
thyroid transcription factor 1 (Titf1), murine elastin (Eln),
murine PDGF-A (Pdgfa), murine alpha smooth muscle
actin (Acta2), murine Caspase 3 (Casp3), murine IL-1b
(Il1b), murine CXCL1/KC (Cxcl1), murine CXCR2 (Cxcr2),
murine VEGF (Vegfa), murine GAPDH (Gapdh), and
housekeeping gene mouse ß-actin (ACTB) was performed
on a ABI PRISM 7700 Sequence Detection System using
Pre-Developed TaqMan Assay Reagents (Applied Biosys-
tems, Foster City, CA). Quantitative analysis of gene
expression was performed using the comparative CT (ΔCT)
method, in which CT is the threshold cycle number (the
minimum number of cycles needed before the product can
be detected) [15]. The arithmetic formula for the ΔCT
method is the difference in threshold cycles for a target (i.e.
IKKb) and an endogenous reference (i.e. housekeeping
gene b-actin). The amount of target normalized to an
endogenous reference (i.e. IKKb in double transgenic ani-
mals) and relative to a calibration normalized to an endo-
genous reference (i.e. IKKb in controls) is given by 2
-ΔΔCT.
TUNEL assay for apoptosis
Paraffin-embedded tissue sections prepared from select
embryonic and postnatal day lungs of double transgenic
Nkx2.1;IKKß
F/F and control IKKb
F/F mice were pro-
cessed using a terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labeling (TUNEL) detection
kit as described by the manufacturer (In situ Cell Death
Detection Kit, Roche Applied Science, Indianapolis, IN).
Briefly, tissue sections were deparaffinized and rehy-
drated through a graded series of alcohols and washed
in distilled-deionized H2O. Following treatment with
proteinase K, the slides were washed with PBS and incu-
bated at 37°C for 1 h with TUNEL reaction mixture
containing fluorescein-tagged dUTP antibody (to detect
DNA strand breaks) per kit instructions. Samples were
analyzed by fluorescence microscopy using a Zeiss Axio-
plan microscope and fluorescence detection system
(OPTI-QUIP, Inc., Highland Mills, NY) to detect differ-
ences in apoptotic cells in transgenic versus wild-type
lungs. Data were quantified by performing manual cell
count of TUNEL-positive cells for each section.
siRNA knockdown of IKKb
MLE-15 (immortalized murine distal respiratory epithe-
lium) cells were cultured at 37°C in a humidified chamber
supplemented with 5% CO2. Reverse transfection with
Silencer Select siRNA (Applied Biosystems, Foster City,
CA) was used with Lipofectamine RNAiMAX (Invitrogen
Corp., Carlsbad, CA) to interrogate MLE-15 cell response
to knockdown of IKKb, VEGF, and GAPHD according to
the manufacturer’s protocol. After optimizing transfection
of the siRNA, cells were collected and total mRNA was
isolated for real time quantitative PCR analysis. GAPDH
siRNA transfected cells were used as a positive control
and markers for cell death were analyzed for quality assur-
ance. Real-time quantitative PCR using primers to detect
mouse IKKb (Ikbkb), murine Caspase 3 (Casp3), murine
B c l 2( B c l 2 ) ,m u r i n eV E G F( V e g f a ) ,m u r i n eG A P D H
(Gapdh), and housekeeping gene mouse ß-actin (ACTB)
was performed on a ABI PRISM 7700 Sequence Detection
System using Pre-Developed TaqMan Assay Reagents
(Applied Biosystems, Foster City, CA) as described above.
Statistical Analysis
Data were analyzed using the Microsoft Excel 2003 sta-
tistical package (Microsoft Corporation). Two group
comparisons were evaluated using the unpaired Stu-
dent’sttest. Data were expressed as mean ± SEM where
appropriate.
Results
Global deletion of the IKKa subunit of IB kinase
complex disrupts lung saccularization
Since literature describing the developmental impact of
key subunit deletions of the IKK complex (IKKa and
IKKb) showed embryonic lethality and did not specifi-
cally focus on lung development [8,9,31,32], we
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mice exhibit any morphologic changes. A detailed histo-
logical analysis of lung sections from IKKa -/- knock-
outs at E13, E16, and E18 embryonic stages (kindly
provided by Inder Verma, UCSD) showed that while no
obvious differences were noted at E13 or E16, lung sec-
tions at E18 had larger airspaces with thinning of
mesenchyme when compared to wild type controls [Fig-
ure 1A-H]. Quantitative analysis showed a significant
decrease by 45% in the number of alveolar type II cell
precursors identified by expression of Nkx2.1 [Figure
2A-C]. Notably, immunohistochemical analysis for pro-
liferating cell marker ki67 demonstrated a significant
decrease in proliferating cells throughout the lung
mesenchyme and epithelium in IKKa -/- knockout
lungs as compared to wild type controls. TUNEL stain-
ing also showed more epithelial cells undergoing apop-
tosis in IKKa -/- knockout lungs [Figure 2D]. These
data demonstrate that deletion of IKKa influences lung
saccularization and suggest that the IKK signaling com-
plex may regulate lung morphogenesis in late gestation
through changes in cell proliferation and apoptosis.
Conditional deletion of IKKb in lung epithelium
Given similar reports describing embryonic lethality
associated with global deletion of IKKb [8,31,32], and
Figure 1 Global deletion of IKKa disrupts saccular formation. Representative hematoxylin and eosin stained photomicrographs of lung
tissue from embryonic stages E13-E18 from wild type littermate controls (A-C; G) and homozygous IKKa -/- knockout progeny (D-F; H). [4 ×
magnification in A-F; 10 × magnification in G-H (E18)].
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of canonical NF-B activation and gene transcription
[33], we designed a targeted approach for tissue-specific
deletion of IKKb in lung epithelium using a transgenic
Cre/loxP recombination strategy. Homozygous floxed
IKKb
F/F mice (a kind gift of M. Karin, UCSD) in which
E x o n3o ft h eI K K b gene is flanked by loxP sites were
crossed to mice containing the Nkx2.1-Cre transgene
Figure 2 Global deletion of IKKa decreases alveolar type II cell precursors. (A, B) Immunohistochemistry for Nkx2.1 with quantification of
Nkx2.1-positive cells in (C) at E18. (D) Immunohistochemistry representing proliferation marker ki67 (top panels) with TUNEL stain representing
cell apoptosis (bottom panels). [20 × magnification in A-B; 4 × magnification in D; Data are expressed as Mean ± SEM, *p < 0.05 in C].
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factor, TTF-1, is specifically expressed in forebrain, thyr-
oid, and lung epithelium; [25,26]). Following an initial
cross to generate heterozygous (Nkx2.1
Cre; IKKb
F/+) ani-
mals, these were then back-crossed to homozygous
IKKb
F/F mice to generate double-transgenic (Nkx2.1
Cre;
IKKb
F/F) progeny [Figure 3A]. Following confirmation of
genotype via PCR analysis [Figure 3B], deletion of IKKb
in lung tissue was assessed by PCR analysis using pri-
mers designed to detect the presence or deletion of
Exon 3 through specific primer combinations [Figure
3C]. Real time quantitative PCR from total lung RNA
confirmed a significant decrease (by 60%) in IKKb
mRNA levels in whole lungs of double-transgenic versus
control (IKKb
F/F) animals [Figure 3D]. Finally, immuno-
histochemical analysis showed decreased lung IKKb pro-
tein expression in alveolar epithelial cells of double-
transgenic lungs [Figure 3E] and a blunted inflammatory
response to the endotoxin lipopolysaccharide (LPS) was
noted in adult double-transgenic mice as compared to
controls (Lopez B, Maisonet TM, Londhe VA: Alveolar
NF-B signaling regulates endotoxin-induced lung
inflammation in mice, Submitted). Of note, double-
transgenic animals survived normally into adulthood
with no obvious signs of sickness or evidence of respira-
tory compromise. These data demonstrate the successful
generation of a mouse model to study the effects of
epithelial IKKb deletion in vivo.
Epithelial deletion of IKKb delays alveolar formation
Histological analysis of lung sections spanning from
E12 thru postnatal stages revealed no differences in
lung morphology in embryonic stages until postnatal
days P0 and P7, which showed enlargement of saccu-
lar and alveolar airspaces in double-transgenic mice
[Figure 4A-L]. Alveolar enlargement at P7 was quanti-
fied through significant decreases in morphometric
radial alveolar counts that correspond to larger alveoli
[Figure 4O]. Interestingly, histological findings
resolved spontaneously with normalization of radial
alveolar counts by the completion of alveolar forma-
tion at P30 and remained normal into young adult-
hood [Figure 4M-O]. Further, a rigorous analysis of
multiple serial histological sections from each double-
transgenic lung at each postnatal time point showed
no evidence of active or resolving inflammation and
no significant difference in expression of inflammatory
chemokines interleukin (IL-1b), CXCL1/KC (neutro-
phil chemoattractant), or CXCR2 (neutrophil chemo-
kine receptor) as compared to wild type littermate
controls [see Additional File 1]. These data demon-
strate that deletion of IKKb in alveolar epithelium
impairs early alveolar formation independent of
inflammation.
Epithelial deletion of IKKb results in fewer alveolar type I
and type II cells
To determine which specific cell type(s) were affected by
epithelial IKKb deletion, we focused on Nkx2.1 and sur-
factant protein C (SP-C), known markers for alveolar
epithelial cells and precursors to alveolar type II cells.
We also examined T1a, expressed by alveolar type I
cells, to determine the potential impact on alveolar type
II to type I cell differentiation. Immunohistochemical
analysis showed a marked decrease in the number of
alveolar type II cells in double transgenic lungs com-
pared to controls [Figure 5A-C]. Similarly, real time
quantitative PCR also showed decreased Nkx2.1 mRNA
levels [Figure 5D]. Quantification of alveolar type I cells
was estimated through immunofluorescence for T1a
(alveolar type I-specific protein) followed by binary
image conversion and summation of pixel numbers cor-
responding to alveolar type I cell distribution as pre-
viously described [29] [Figure 5E &5F]. Results showed
proportional decreases in SP-C-positive cells and T1a
distribution in double transgenic lungs at P7 [Figure 5G
&5H]. These data demonstrate that epithelial IKKb dele-
tion leads to a proportional decrease in the number of
alveolar type I and II cells.
Alveolar formation is impaired through altered lung
septation
To determine which genes may be responsible for the
observed alveolar changes in double transgenic lungs, we
queried relevant lung morphoregulatory genes known to
be expressed at a critical period during alveolar septation.
Hart’s elastin stain at P7 showed a marked absence of sec-
ondary crests expressing elastin, an interstitial matrix pro-
tein involved in initiation and progression of alveolar
formation [34,35], in double transgenic versus control sec-
tions [Figure 6A-B]. Real-time quantitative PCR confirmed
a significant decrease in elastin mRNA expression and
demonstrated a similar decrease in levels of platelet-
derived growth factor (PDGF-A) and a-smooth muscle
actin (a-SMA), differentiation markers expressed during
alveolar maturation [36] by lung epithelium and lung myo-
fibroblasts, respectively [Figure 6C-E]. In addition, we per-
formed immunofluorescence analysis of a-SMA-positive
cells in lung parenchyma to quantify potential changes in
myofibroblast numbers. Results showed significant
decreases in numbers of myofibroblasts in double trans-
genic lungs as compared to controls at P7 [Figure 6F-H].
Epithelial deletion of IKKb enhances cell apoptosis
To determine the cellular processes by which epithelial
deletion of IKKb alters secondary crest formation, we
analyzed known functions of the IKK/NF-B signaling
complex that include cell proliferation and inhibition of
apoptosis [37]. A proliferation assay to detect Ki67, a
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demonstrable differences between double transgenic ver-
sus control lungs (data not shown). In contrast, assays
to detect apoptosis via real time quantitative PCR
showed that Caspase 3, a marker of apoptosis, was sig-
nificantly increased in the early postnatal period [Figure
7A]. Similarly, apoptosis detected by TUNEL assay con-
firmed markedly increased apoptotic cells in an
Figure 3 Generation of Nkx2.1/IKKb
F/F double transgenic mice. (A) Simplified breeding schema representing cross of Nkx2.1-Cre and
homozygous IKKb
F/F mice resulting in deletion of exon 3 of IKKb gene. (B) Genotyping PCR analysis identifying double transgenic (Nkx2.1/IKKb
F/F)
and control (IKKb
F/F) progeny. (C) PCR primer design to confirm lung epithelium selective deletion of IKKb. (D) Real-time quantitative PCR and (E)
Immunohistochemistry confirming decreased expression of IKKb in lung tissue. [Data are expressed as Mean ± SEM, *p < 0.05 in D; Arrows pointing
to IKKb-positive alveolar type II cells in top panel and IKKb-negative alveolar type II cells in bottom panel in (E)].
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7B]. These data demonstrate that deletion of IKKb in
alveolar epithelium leads to fewer alveolar type II cells
through increased cell apoptosis and identifies regula-
tion of cell apoptosis as an important function of NF-B
signaling during alveolar development.
Epithelial deletion of IKKb decreases VEGF expression
Finally, to identify the molecular mechanisms of delayed
alveolar formation from loss of AT2 cells in our model, we
measured expression of VEGF, known to be secreted by
the alveolar epithelium [22] and an important mediator of
epithelial-endothelial signaling. Results showed marked
Figure 4 Epithelial deletion of IKKb delays alveolar formation. Representative hematoxylin and eosin stained photomicrographs of lung
tissue from embryonic (E12-E17), early postnatal (P0, P7) and young adulthood (P30) stages from IKKb littermate controls (A-N; top panels) and
double transgenic Nkx2.1/IKKb
F/F progeny (A-N; bottom panels). (O) Radial alveolar counts at P7 and P30. [4 × magnification in A-L; Data are
expressed as Mean ± SEM, * p < 0.05 in O].
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Page 9 of 16Figure 5 Epithelial deletion of IKKb decreases alveolar type I and II cells numbers. (A, B) Immunohistochemistry for Nkx2.1 with
quantification of Nkx2.1-positive cells in (C) at P7. (D) Real-time quantitative PCR confirming decreased expression of Nkx2.1 mRNA in double
transgenic compared to control lungs. Immunofluorescence for SP-C (green channel) and T1a (red channel) in control (E) versus double
transgenic lungs (F) with respective quantification (G, H) at P7. [10 × magnification; insets represent binary image of T1a-positive pixels; Data are
expressed as Mean ± SEM, *p < 0.05 in C-D and G-H].
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Page 10 of 16Figure 6 Alveolar formation is impaired through altered lung septation. Hart’s elastin stain in control (A) versus double transgenic (B) lungs
at P7. Real-time quantitative PCR showing expression of (C) elastin, (D) PDGF-A and (E) a-SMA. Immunofluorescence for a-SMA representing
myofibroblasts in control (F) versus double transgenic (G) lungs at P7 with quantification in (H). [40 × magnification in A, B, F, G with insets 80 ×
magnification and arrows pointing to elastin expression in A & B, and arrows pointing to myofibrobasts in F & G; Data are expressed as Mean ±
SEM, * p < 0.05 in C-E, and H].
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Page 11 of 16decrease in VEGF protein expression in the distal airways
of double transgenic lungs (Figure 8A & B) and significant
decrease of total lung VEGF mRNA as compared to con-
trols (Figure 8C). To confirm that VEGF decreased in spe-
cific response to deletion of IKKb,a nin vitro approach
using the immortalized mouse lung epithelial cell line
MLE-15 showed that siRNA knockdown of IKKb signifi-
cantly decreased VEGF (by 80%). Nonspecific effects of
siRNA knockdown were ruled out using appropriate posi-
tive and negative controls (Figure 8D). Specifically, siRNA
against IKKb did not induce apoptosis in MLE-15 cells as
demonstrated by no change in expression of Bcl2 or Cas-
pase-3 (data not shown). These findings identify the
importance of IKKb/NF-B signaling in regulating VEGF
and epithelial-endothelial crosstalk.
Discussion
Alveolar formation is a complex developmental program
during late gestation/early postnatal life in mammals that
can be easily perturbed by inflammation. We previously
found that overexpression of the RelA subunit of NF-B
accelerates lung maturation as evidenced by increased
alveolar epithelial cells [15]. We therefore hypothesized
that inactivation of NF-B would conversely impair alveo-
lar formation. Our results demonstrated that targeted
deletion of IKKb in the lung epithelium reduces the num-
ber of alveolar type I and II cells and transiently impairs
alveolar secondary crest formation. IKKb deletion reduced
alveolar epithelial cells through increased cell apoptosis
and was associated with decreased VEGF expression. Col-
lectively, these findings highlight an important function of
NF-B in controlling early alveolar development.
Since the original description of NF-Bm o r et h a n
twenty years ago [38,39], a number of studies have
investigated its role in developmental organogenesis.
Relevant early studies in knockout animals for the RelA
(p65) subunit described embryonic lethality at E15.5-
E16.5 due to massive liver apoptosis [2]. Similarly, global
Figure 7 Epithelial deletion of IKKb enhances cell apoptosis. (A) Real-time quantitative PCR showing lung Caspase-3 expression at indicated
embryonic and postnatal stages. (B) TUNEL stain with quantification of TUNEL-positive nuclei at P0. [Bars in (A) represent fold induction in
double transgenic compared to control lungs; Data are expressed as Mean ± SEM, * p < 0.05].
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Page 12 of 16deletion of IKKb also resulted in lethality at E13.5-E14.5
from liver apoptosis [8,31,32] while deletion of IKKa
proved lethal immediately after birth due to epidermal
defects [5,9]. Although the homozygous progeny in
these studies were noted to have abnormalities of cell
apoptosis in specific organs, no obvious signs of devel-
opmental lung abnormalities were reported. Evidence
supporting a potential role of NF-B in lung morpho-
genesis was first demonstrated in studies of the chick
embryo in which experimentally-induced perturbations
of NF-B gene expression in lung mesenchyme resulted
in abnormal lung branching morphogenesis [10]. The
results showed that overexpression of NF-B targeted to
lung mesenchyme via adenoviral vector delivery inhib-
ited branching during early lung morphogenesis. Addi-
tional indirect evidence of NF-B signaling in fetal
mouse lungs was also shown through intra-amniotic
injection of LPS with activation of Toll-like receptor
(TLR4) upstream of NF-B that increased alveolar type
II cells as described above [17,40]. Taken together with
our previous report of maturational effects of NF-B
overexpression [15], these studies support a link
between NF-B and lung morphogenesis.
The property of NF-B as an inhibitor of apoptosis is
well described [37]. Apoptosis describes the final step of a
cell’s normal lifespan and is a distinct form of pro-
grammed cell death characterized by loss of cell function
and morphological changes. Apoptosis leads to cell death
without inflammation and serves an important function
throughout alveolar development, especially during septa-
tion. Apoptotic changes are first noted in mesenchymal
tissue during early development followed by a shift to both
mesenchymal and epithelial tissue layers as alveoli form
[19]. Interestingly, rodent models have demonstrated that
the numbers of alveolar type II cells (the putative precur-
sors of type I cells) are in excess just prior to the comple-
tion of alveolar formation [20]. A transgenic mouse model
targeting overexpression of the Fas ligand to lung
Figure 8 Epithelial deletion of IKKb decreases VEGF expression. Immunofluorescence showing VEGF expression in control (A) versus double
transgenic (B) lungs. (C) Real-time quantitative PCR showing VEGF expression. (D) Real-time quantitative PCR from siRNA knockdown in MLE-15
cells in vitro showing Gapdh, Vegf, and IKKb expression. [Data are expressed as Mean ± SEM, *p < 0.05].
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Page 13 of 16epithelium recently showed that excessive cell apoptosis
caused disruption of alveolar development [21]. The acti-
vators that lie upstream of NF-B and regulate anti-apop-
totic properties largely include TNF ligands (Tumor
Necrosis Factor) and TNFRs (TNF-receptors) [41,42].
Some TNF/TNFRs activate the expression of inhibitor of
apoptosis proteins (IAPs). TNFR ligands also transduce
cellular responses through TNFR-associated factors, also
known as TRAFs. Specifically, TRAF2 and TRAF5 are
known to activate NF-B and ultimately prevent cell apop-
tosis. Apoptosis of lung epithelial cells thus emerges as an
important process in regulating a balance between those
cells that are redundant versus those that ultimately con-
tribute to alveolar maturation.
Results of the current study showed that targeted dele-
tion of IKKb in lung epithelium increased cell apoptosis
and led to early postnatal alveolar hypoplasia. Although
previously unreported, global deletion of IKKa also
resulted in fewer and larger alveoli in E18 lungs. The sig-
nificance of these observations is noteworthy since IKKa
and IKKb are known to exert their effects through diver-
gent signaling pathways [37]. IKKa is a participant of
both canonical as well as non-canonical NF-Bs i g n a l
transduction. In the canonical pathway, it forms a hetero-
dimer with IKKb following activation by stimuli such
tumor necrosis factor alpha (TNFa), interleukin-1 (IL-1),
or lipopolysaccharide (LPS); whereas in the non-canoni-
cal pathway, IKKa forms homodimers with itself after
activation by NF-B -inducing kinase (NIK). Activation
of IKKa via this non-canonical pathway engages a pro-
proliferative function through induction of p52 and
cyclin D promoter activity, and also plays an independent
role in regulating differentiation of certain cell types. A
minor role in anti-apoptotic function has also been
described [33]. In comparison, the consequences of IKKb
activation stimulate largely anti-apoptotic, pro-inflamma-
tory, and some pro-proliferative mechanisms. Our data
showing a significant decrease in cell proliferation follow-
ing global IKKa deletion and an increase in cell apoptosis
following targeted IKKb deletion thus support the con-
cept that NF-B plays a critical role in regulating cell sur-
vival during early alveolar development.
The findings from our study showing decreased epithe-
lial VEGF expression following conditional IKKb deletion
and siRNA knockdown associated with delayed alveolar
formation are consistent with previous reports that the
VEGF/VEGF-receptor system mediates a link between
branching morphogenesis, vascular development, and
morphogenesis of the pulmonary epithelium [43]. VEGF
(specifically isoform VEGF-A) has been shown to be
secreted by peripheral epithelial cells at the tips of devel-
oping respiratory tubules. Inactivation of VEGF-A in
respiratory epithelium results in almost complete absence
of pulmonary capillaries and leads to defects in primary
septae formation presumably by interruption of a para-
crine interaction necessary for coordination of pulmon-
ary and epithelial vascular development [44]. VEGF
deficiency was also recently shown in a mouse model of
diabetes-induced respiratoryd i s t r e s ss y n d r o m ea n ds u r -
factant deficiency demonstrating its critical angiogenic
role required for maturation of alveolar epithelium [45].
Similarly, exogenous intratracheal delivery of VEGF pre-
vented fatal respiratory distress in premature mice [46]
and stimulation of VEGF production conferred protec-
tion against acute lung injury [47]. Interestingly, new evi-
dence suggests that VEGF itself may also possess an anti-
apoptotic function in the context of acute lung injury
such as hyperoxia exposure and mechanical stretch of
alveolar epithelium [47,48]. Iti st h u si n t r i g u i n gt oc o n -
sider the possibility that increased AT2 cell apoptosis
observed in our model might be a consequence of either
direct loss of IKKb/NF-B activity or an indirect effect
through loss of a protective function of VEGF, although
the exact details remain unclear.
Potential limitations of the current study that are
important to consider are that Nkx2.1 promoter activity
is present in the forebrain and thyroid in addition to the
lung epithelium. It is thus conceivable that potential
effects on respiratory drive in utero or postnatally could
lead to changes in lung architecture. Similarly, changes
in thyroid metabolism could also have potential impact
on lung development. Although these possibilities exist,
we did not observe any obvious changes in respiratory
pattern or metabolic activity (e.g. weight gain or loss) in
double transgenic versus control animals.
Conclusions
In conclusion, we have developed an animal model in
which targeted deletion of NF-B signaling in the lung
epithelium results in alveolar hypoplasia. The clinical
relevance of our model may be applicable to disorders
of alveolar formation such as bronchopulmonary dyspla-
s i ai nw h i c ht h ep r i m a r yp a t h o l o g ya p p e a r st ob ea n
arrest or impairment of alveolar secondary crest forma-
tion. Our model may prove particularly useful to study
the molecular mechanisms whereby inflammatory
insults or other environmental factors such as oxidative
stress, etc., might further impact NF-B to permanently
impair normal lung morphogenesis.
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Additional file 1: Expression of inflammatory chemokines. Realtime
quantitative PCR showing no significant differences in IL-1, CXCL1/KC, or
CXCR2 expression at P0. [Data are expressed as Mean ± SEM]
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